Profound understanding of the relationship between molecular structure and biological activity is an essential prerequisite for rational drug design. Due to the inherent non-linearity of these relationships, ordinary regression is often inadequate, and black-box machine learning approaches offer limited, if any, interpretability. As a solution, we propose to use symbolic regression, in conjunction ...